Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD2389 | FAP Inhibitor | MedChemExpress
AZD2389
AZD2389 | ≥99%(HPLC) | Selleck | Immunology & Inflammation related 阻害剤
AZD2389 (R)-3-glycylthiazolidine-4-carbonitrile hydrochloride ...
AZD2389 | Immunology & Inflammation related 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话 ...
AstraZeneca Initiates Phase I Studies of AZD2389 for Liver Fibrosis and ...
首次！2025年12款小分子新药结构揭晓_腾讯新闻
美国CAS春季研讨会探讨——共价化合物 - 知乎
Chemical structures of compound AZD-3293. a AZD-3289 is a potent BACE1 ...
A Phase 2a, Randomised, Single-blind, Placebo-controlled Study to ...
All three components of AZD6389 are required for closure of the ...
ADP2389 Datasheet and Product Info | Analog Devices
Preclinical Research on FAP-Related Targets: AstraZeneca's Approach ...
FAP | 成纤维细胞激活蛋白 | MCE
A single and multiple ascending dose study to investigate safety ...
PF-07220060
Figure 3 from Development of a Preclinical PK/PD Model to Assess ...
AstraZeneca Completes Phase 2a Study on Liver Fibrosis Treatment ...
Design, Synthesis, and Biological Evaluation of Potent and Selective ...
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib ...
Drug Hunter - drug discovery, distilled
AZD-2389 - Drug Targets, Indications, Patents - Synapse
Optimizing Preclinical Toxicology Data Analysis | Excelra
Characterisation of pharmacokinetics, safety and tolerability in a ...
Astrazeneca: Educational Booklet Asthma on Behance
Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human ...
Discovery and pharmacological characterization of AZD3229, a potent KIT ...
Targeting a single pathogen with AZD6389 accelerates polymicrobial ...
Table 1 from Oral direct thrombin inhibitor AZD0837 for the prevention ...
ATM inhibitors: AZD0156 was modified to AZD1390, an orally available ...
(PDF) Oral direct thrombin inhibitor AZD0837 for the prevention of ...
Effects of AZD 8529 on nicotine and food self-administration in ...
Events | Discovery Intermediate School
培美曲塞二钠(Pemetrexed Disodium Hydrate) - 药物靶点：DHFR x GART x TYMS_在研适应症：局部 ...
靶向实体瘤另辟蹊径：成纤维细胞激活蛋白(FAP) FAP概述FAP（Fibroblast activation protein-α）是一种97 ...
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral ...
AURORA震旦ADT-289碳粉震旦复印机原装AD289粉盒粉仓粉筒墨粉_虎窝淘
Les Tari - Cidara Therapeutics | LinkedIn
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and ...
12 drug candidates debut in San Diego
Azd0780 – Application in Therapy and Current Clinical Research
Figure 1 from Oral direct thrombin inhibitor AZD0837 for the prevention ...
Azathioprine desensitizes mdx FAPs to insulin. (A) Schematic ...
IJMS | Special Issue : Advances in Photopharmacology
盐酸安非他酮(Bupropion Hydrochloride) - 药物靶点：CYP2D6 x DAT x NET x adrenergic ...
EGFR signaling pathway - Blog
Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor ...
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a ...
(PDF) AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2 ...
阿斯利康终止多款管线！包括MASH、肿瘤、合作药物医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
AZD1390 | ATM Inhibitor | CAS 2089288-03-7 | Selleck Chemicals
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
Effect of Solvents on the Time-Dependent Inhibition of CYP3A4 and the ...
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor ...
FAP Inhibitor Market Size, Target Population, Competitive Landscape
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC ...
Plasma Protein Binding as an Optimizable Parameter for Acidic Drugs ...
Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia ...
Frontiers | Small Molecule Inhibitor C188-9 Synergistically Enhances ...
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell ...
Effects of acute AZD8418 and AZD8529 administration on nicotine and ...
Selection and Development of a Route for Cholesterol Absorption ...
Ahmad Shah Al-Jeffry A To Z : The Identification Of Potent Selective ...
Small-molecule inducers of insulin expression in pancreatic α-cells | PNAS
Missy McCarthy - Human Resources Specialist at Verizon | LinkedIn
AZD7648 and olaparib combination has antiproliferative efficacy. a ...
Table 1 from Pharmacology of the ATM Inhibitor AZD0156: Potentiation of ...
Human clinical ADME/PK of 50 new drug candidates and drugs (highlighted ...
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Figure S1. Effect of AZD8529 on nicotine-induced elevations of ...
FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis ...
Small Molecule Highlights #24 – April 2024 – Dalriada Drug Discovery
The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands ...
Accelerating drug discovery | therapeutics | structural biology
Effects of repeated AZD8529 on nicotine and food self-administration ...
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist ...
osimertinib « New Drug Approvals
Co-treatment with AZD1775 and olaparib significantly inhibited tumor ...
Novel Generation of FAP Inhibitor-Based Homodimers for Improved ...
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone ...
coronary artery disease « New Drug Approvals
Myocardial Steatosis and Necrosis in Atria and Ventricles of Rats Given ...
Neglected Nitriles: An Underutilized Cysteine Reactive Warhead?
Comparison of the bronchodilator and systemic effects of AZD3199, an ...
AZD7648 is a potent and selective DNA-PK inhibitor that enhances ...
Oncology Reports
Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic ...
The initial metabolic sites of AZD7325 (marked in red) and subsequent ...
Pharmacological Inhibition of Brain EGFR Activation By a BBB ...
